Emerging companies and investors alike are navigating a landscape marked by rapid technological advancements, intense competition, and evolving regulatory frameworks, whilst themselves trying to transform the modern world. The need for innovative solutions, strategic partnerships, and access to capital is more critical than ever. Entrepreneurs must balance the drive for growth with the complexities of scaling their businesses globally, while investors seek to identify and nurture the next wave of market disruptors.

At Shoosmiths, we understand these dynamics and are committed to helping you thrive. Our team provides comprehensive legal support across the full lifecycle of venture capital transactions, from funding rounds to global expansion plans to exit strategies. Our track record speaks for itself, with the team advising on more venture and growth capital deals than any other UK law firm (source: Pitchbook Annual League Tables 2024).

Alongside our extensive company side work, we also act on a serial basis for the likes of MMC, Lakestar, Business Growth Fund, Octopus Ventures, Foresight, Gresham House Ventures, Clean Growth Fund, Triple Point Ventures, Oxford Capital, Mercia Ventures, Edge, Salica Investments, Blackfinch and other high-profile institutional investors.

This gives us an ‘all round’ perspective on the negotiation steps and an ability to find solutions to get deals done.

As a result, we offer a seamless service for companies and investors from early-stage seed investments to series A, series B and later investment rounds, helping businesses rapidly scale and eventually successfully exit.

• advising Lakestar on its investment in Vertice as part of a $50 million Series C funding round into the AI-powered spend optimisation platform

• advising Oasthouse Ventures on its investment raise to fund the $104.8 million first phase of America’s largest greenhouse project in Virginia

• advising Amadeus Capital Partners on its investment into Inotec AMD as part of a $33 million funding round to support the growth of its award-winning wound-healing medical technology

• advising DEScycle on its £10.2 million Series A investment round led by BGF and Vorwerk, supporting its sustainable gold extraction technology using deep eutectic solvents

• advising Lakestar on its £35 million investment into Doccla, a leading virtual hospital platform, to support its European expansion and real-time remote patient monitoring technology

• advising DTCP on its primary and secondary investment into Dexory as part of an $80 million round to support the growth of its robotics and AI-driven logistics technology.